MERKURID, LLC
Products, services
- Mercurid;
- Multitarget therapy;
- Epigenetic therapy;
- Long-term use of Mercureid;
- Innovative nanomolecules;
- SMART molecules - Smart molecules.
- Multitarget therapy;
- Epigenetic therapy;
- Long-term use of Mercureid;
- Innovative nanomolecules;
- SMART molecules - Smart molecules.
Company information
Mercurid is a research biopharmaceutical company that develops and implements innovative drugs in areas with unmet medical needs.
”Mercurid” - targeted immunotherapy of the new generation:
- Multi-target therapy for key proteins and genes responsible for the development of chronic inflammation, fibrosis, cancer.
- Epigenetic therapy to disable malfunctioning genes that cause tumor growth.
- Prolonged use of Mercureid is safe for the patient, not addictive. Potentiates the therapeutic effect.
- Innovative nanomolecules have a targeted effect on proteins that ”malfunction” without affecting normal cells.
- SMART molecules - SMART molecules. A new class of molecules to implement only the therapeutic effect, which reduces the risk of side effects to zero.
- Mercureid - elimination not of symptoms of a disease, and the reasons at a genetic level.
The company creates innovative molecules ”First-in-Class, NME”, aimed at cytokines, chemokines, receptors, kinases, signal transduction pathways critical in the pathogenesis of autoimmune, immunoinflammatory diseases, oncoimmunology.
The company’s mission is to provide patients with modern, affordable, highly effective drugs. Improving the quality and life expectancy of patients are the company’s top priorities in drug development.
”Mercurid” - targeted immunotherapy of the new generation:
- Multi-target therapy for key proteins and genes responsible for the development of chronic inflammation, fibrosis, cancer.
- Epigenetic therapy to disable malfunctioning genes that cause tumor growth.
- Prolonged use of Mercureid is safe for the patient, not addictive. Potentiates the therapeutic effect.
- Innovative nanomolecules have a targeted effect on proteins that ”malfunction” without affecting normal cells.
- SMART molecules - SMART molecules. A new class of molecules to implement only the therapeutic effect, which reduces the risk of side effects to zero.
- Mercureid - elimination not of symptoms of a disease, and the reasons at a genetic level.
The company creates innovative molecules ”First-in-Class, NME”, aimed at cytokines, chemokines, receptors, kinases, signal transduction pathways critical in the pathogenesis of autoimmune, immunoinflammatory diseases, oncoimmunology.
The company’s mission is to provide patients with modern, affordable, highly effective drugs. Improving the quality and life expectancy of patients are the company’s top priorities in drug development.
Activities of KVED
- Research and experimental development in the field of biotechnology
- Production of perfumery and cosmetics
- Manufacturing of pharmaceuticals
- General medical practice
- Retail sale of pharmaceutical products in specialized stores
- Research and experimental development in the field of other natural and technical sciences
Questions and answers
According to the Unified State Register of Enterprises and Organizations of Ukraine to a legal entity «MERKURID, LLC» assigned a code 33073023.
Head of the company «MERKURID, LLC» is Husev Serhii Mykolaiovych, according to the data of the Unified State Register of Enterprises and Organizations of Ukraine.
According to the Unified State Register of Enterprises and Organizations of Ukraine legal address of the company «MERKURID, LLC» — m. Odesa, vul. Rozkydailivska, 69/71.
According to information obtained from open and reliable Internet sources, at the enterprise «MERKURID, LLC» official site: http://www.mercurid.com/
Legal entity status according to the Unified State Register (EDRPOU) — registered.
What do you think of the company «MERKURID, LLC». Share your thoughts in the comments!
Share information on social networks
